Idorsia aims to be Europe’s leading biopharmaceutical company, with a strong scientific core. We provide regular updates on the progress being made towards this goal. This section of the website provides journalists with additional material to support the generation of articles.

Events

Event When
Credit Suisse Annual Healthcare Conference November 8-11, 2021
Jefferies Global Healthcare Conference November 16-18, 2021
Credit Suisse Equity Forum November 16-19, 2021
Evercore ISI HealthCONx Conference November 30-December 2, 2021
Full-Year 2021 Financial Results reporting* February 8, 2022

Annual General Meeting of Shareholders

April 14, 2022
First-Quarter 2022 Financial Results reporting*
April 26, 2022
Half-Year 2022 Financial Results reporting*
July 26, 2022

*We will be in a silent period for 10 days ahead of the financial reporting.

Stay informed

Idorsia offers an electronic ‘Stay Informed’ service where subscribers can automatically receive updates via e-mail or SMS alert.

Stay informed

Social Media

Idorsia is active on social media – follow our channels to get a more personal view on the company.

Social Media

Media center

Idorsia provides images, fact sheets and B-roll to download or support you with your article.

Media center

Contact

Contact

Andrew C. Weiss

Senior Vice President, Head of Investor Relations and Corporate Communications

Media Relations

Resources in German

Als schweizerisches Unternehmen stellen wir interessierten Personen auf dieser Seite wesentliche Informationen über unser Unternehmen in deutscher Sprache zur Verfügung.